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ABSTRACT
INTRODUCTION. According to a prominent study, 80-90% of people will show some
evidence of degenerative disc disease (DDD) by age 50. Researchers have proposed that a
Q326W substitution in the COL9A2 gene increases susceptibility to DDD. The role of collagen
IX in intervertebral discs is not completely known, but due to its increased flexibility compared
to other types of collagens, it is thought to connect collagen II with other components of the
cartilage which are important to the integrity of the disc. Collagen II can be found within the
nucleus pulposus and the inner portion of the annulus fibrosis. Researchers have also suggested
that the heterozygous form of the TaqI polymorphism can increase susceptibility to DDD.
Vitamin D plays a role in sulphate metabolism. Therefore, the extent to which the vitamin D
receptor (VDR) is expressed can affect sulphation of glycosaminoglycans during proteoglycan
synthesis which can impact the structural integrity of the extracellular matrix of the nucleus
pulposus. Following previous research that demonstrated successful genomic DNA (gDNA)
isolation from embalmed tissues, this project attempted to analyze the VDR and COL9A2 genes
in samples collected from three embalmed female cadaver donors with obvious lumbar DDD.
METHODS. Samples were isolated from four tissues for gDNA extraction: parotid gland,
cerebellum, genioglossus muscle and occipital lobe following approval from the donor
institution. DNA samples were subsequently analyzed for concentration and purity. COL9A2
and VDR specific primers were used for polymerase chain reaction (PCR). Following PCR
amplification and DNA sequencing, samples were compared with published National Center for
Biotechnology Information (NCBI) sequences using BLASTn analysis. SUMMARY. DNA was
successfully extracted from each tissue, but cerebellar and parotid tissue yielded DNA of highest
concentration. The mean purities of each tissue were not significantly different. Nucleotide
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BLAST alignment did not show evidence of the Q326W substitution; however, studies suggest
that this substitution is present in only 4% of patients with a form of DDD. Evidence of the TaqI
polymorphism was not observed either. CONCLUSION. While the Q326W substitution and
TaqI polymorphism were not identified in these cadavers, the ability to successfully extract and
amplify DNA from embalmed tissue was confirmed. This is a preliminary project and additional
genes and donors will be studied in the future.
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INTRODUCTION
Back pain is one of the most common complaints received by primary care physicians.
According to Georgetown University, in addition to the 65 million Americans that have reported
recent back pain, 16 million of them experience that pain chronically. This is nearly 8% of adults
in the United States. By the age of 50, 80-90% of people will show some evidence of
degenerative disc disease on an MRI (Theodore, 2020). When investigating lumbar
spondylolysis specifically, studies show that it appears in 68% of the general population (Leone
et al., 2011). Lumbar spondylosis refers to the hypertrophic response of adjacent vertebral bone
to intervertebral disc degeneration (Middleton & Fish, 2009). Back pain ranges in severity; it can
impede one’s ability to perform daily tasks, it can be a minor discomfort, or it can manifest
somewhere in between. Back pain is a multifactorial issue with a variety of etiologies. One of the
most common causes of back pain is a condition known as degenerative disc disease, also known
as spondylosis (Theodore, 2020). Spondylosis refers to the deterioration of elements of the spine
over time. These elements can include connective tissue, facet joints, and of course,
intervertebral discs (Theodore, 2020). These intervertebral discs are essential to spine mobility.
They allow for smooth vertebral movement as they serve as shock absorbers, preventing the
vertebrae from grinding against one another during movement. Intervertebral discs also play a
role in mitigation of compressive loading as the spine supports the body’s weight.
These intervertebral discs are essential to the function of the spine. Many may not realize
the true importance of the spine. The spine, along with the skull, serves to protect the central
nervous system which consists of the brain and spinal cord. The brain and spinal cord are
arguably the most important structures in the human body. The brain is responsible for
interpreting all of the senses including sight, hearing, touch, smell, and pain. It is also responsible
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for memory, personality, and emotion. The brain is involved in coordinating balance and motor
signals. The brain also controls heart rate, respiratory rate, digestion, and the endocrine system.
The spinal cord is essential to this regulation throughout the body. Every signal from the brain,
whether it be somatic or autonomic, must travel through the spinal cord into the peripheral
nerves. Figure 1 illustrates how the spinal nerves exit from the spinal cord to enter the peripheral
nervous system. If the spinal cord was damaged, those signals from the brain would be unable to
reach their targeted region of the body at and below the damaged portion of the spinal cord. For
example, the brachial plexus is responsible for nerve supply to the upper extremity. It is made up
of spinal nerves C5-T1. If the C5 level of the spinal cord was damaged, all nervous supply of the
upper extremity would be disrupted. In addition, nervous supply to the abdomen, thorax, and
lower extremity would be disrupted as well. Therefore, this spinal cord must be protected well.
This is the function of the spine. The spine acts as a protective layer around the spinal cord to
prevent the cord from being damaged.
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https://moodle.skillscommons.org/pluginfile.php/470/mod_resource/content/2/6BIO168035_print.html
Figure 1: Spinal Nerves Branching from the Spinal Cord

Figure 2 shows a normal MRI of the lumbar spine from the midsagittal view. The
intervertebral discs in Figure 2 are clearly healthy. The light white color of the intervertebral
discs indicates that they are hydrated. Disc desiccation, or a dehydrated intervertebral disc, is a
common symptom of degenerative disc disease (DDD). There is also no obvious bulging or
herniation of the discs anteriorly or posteriorly. In cases of degenerative disc disease, the
intervertebral discs often bulge or herniate posteriorly into the spinal canal which can put
pressure on the spinal cord and spinal nerves. This can result in severe pain. In a healthy spine,
the intervertebral discs should rest between the vertebral bodies. Figure 3 displays the normal
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anatomy of vertebrae. The large portion of the vertebra is known as the body. The intervertebral
discs can be seen between the bodies of two adjacent vertebrae. The facet joint of the posterior
vertebral arch holds the vertebrae together.
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https://radiopaedia.org/cases/normal-lumbar-spine-mri
Figure 2: Normal MRI of the Midsagittal Lumbar Spine

Posterior

Lynn 9

https://www.uscspine.com/spine-health-education/spinal-anatomy/
Figure 3: Normal Vertebral Anatomy
Degenerative disc disease (DDD) is characterized by the intervertebral discs’ loss of
flexibility and height. This can cause pain and inhibit spine mobility. Specifically, DDD is
attributed to the pain associated with intervertebral disc degeneration due to pathologies such as
disc desiccation or bulging due to a weakened annulus fibrosis (Middleton & Fish, 2009). Like
general back pain, DDD is also a multifactorial condition. As mentioned previously, spondylosis
can be characterized by the deterioration of connective structures, facet joints, and intervertebral
discs. Frequently, lumbar spondylosis is an example of a defect in the pars interarticularis of the
vertebrae (Leone et al., 2011). In this study, intervertebral disc herniation and bulging will be
explored.
It is important to discuss what an intervertebral disc is. An intervertebral disc is made up
of a fibrocartilaginous ring around a gel-like center. These discs lie between vertebrae and act as
flexible cushions that carry body weight. These discs are vital to spinal mobility and stability
(Feng et al., 2016). There are two structures that make up an intervertebral disc: the annulus
fibrosis and the nucleus pulposus (Feng et al., 2016). The nucleus pulposus is the gel-like center
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of the disc. Because it is gel-like, it disperses any hydraulic pressure caused by a compressive
load. The nucleus pulposus is gel-like because it is composed of a water-based avascular
substance with a high density of proteoglycans. The main proteoglycan within the nucleus
pulposus is aggrecan. Aggrecan is vital to water retention within the nucleus pulposus.
Dehydration can lead to DDD, but that will be discussed later. Another proteoglycan is versican.
Versican, along with aggrecan, binds with hyaluronic acid and other leucine-rich proteoglycans
(Waxenbaum et al., 2021). This avascular substance also has a small amount of collagen II and
elastin fibers within it that give it this gel-like consistency. The annulus fibrosis surrounds the
nucleus pulposus. The annulus fibrosis is actually composed of fibrocartilage with collagen
fibers. The annulus fibrosis has an inner portion and an outer portion, and each layer has a
different composition. The outer portion of the annulus fibrosis is composed of mainly collagen I
fibers while the inner portion is composed of mainly collagen II fibers (Waxenbaum et al., 2021).
The collagen I fibers are arranged in a lamellar structure with each fiber being oriented at a 30º
angle with respect to vertebral end-plates in the transverse plane (Feng et al., 2016). Lamellae are
highly organized stacks of collagen. The annulus fibrosis is composed of 15-25 lamellae
(Waxenbaum et al., 2021). The lamellae are aligned at 60º angles with respect to other lamellae.
Because of this, alternating lamellae are parallel to each other which allows for incredible
strength. Figure 4 illustrates the alternating lamellae of the annulus fibrosis which results in its
incredible durability. Vertebral end-plates are composed of osseous tissue and hyaline cartilage,
and they supply the discs with nutrients as they extend over and under the inner annulus fibrosis
and nucleus pulposus from the superior and inferior directions (Feng et al., 2016). A herniated
disc occurs due to a tear in the annulus fibrosis which is the circular exterior of the intervertebral
disc. When there is a tear within that annulus fibrosis, the nucleus of the disc may herniate
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through the tear into the spinal canal and impinge on the surrounding nerves which causes pain.
Figure 5 illustrates the normal anatomy of intervertebral discs within the spinal column as well
as an intervertebral disc with the nucleus pulposus herniating through annulus and compressing a
nerve. The injury itself was thought to be caused by a large stress load on the disc, leading to a
loss of structural integrity of the disc. However, recent research suggests that some individuals
may be genetically predisposed to intervertebral discs with compromised structural integrity. A
bulging disc is slightly different in the sense that the nucleus does not completely push through
the annulus fibrosis. Disc herniation is most common in the lumbar spine as it is this part of the
spine that supports the weight of the upper body (Dydyk et al., 2021).

Feng, Y., Egan, B., & Wang, J. (2016). Genetic Factors in Intervertebral Disc Degeneration. Genes Dis,
3(3), 178-185. doi:10.1016/j.gendis.2016.04.005
Figure 4: Structure of Annulus Fibrosis Lamellae
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https://www.physiojpp.com/en/did-you-know-that/discal-hernication
Figure 5: Intervertebral Disc Anatomy
As mentioned previously, degenerative disc disease is attributed to the pain associated
with intervertebral disc degeneration due to pathologies such as disc desiccation or bulging due
to a weakened annulus fibrosis (Middleton & Fish, 2009). As such, DDD can present with
different levels of severity. Intervertebral discs frequently bulge or herniate posteriorly into the
spinal canal which may result in pain due to spinal cord compression. This happens due to the
weakening of the annulus fibrosis of the disc. If the annulus fibrosis has weakened, the nucleus
pulposus will bulge. This is because the structure of the annulus fibrosis is compromised, but the
annulus fibrosis has not completely torn. The annulus fibrosis is still capable of containing the
nucleus pulposus within it. Figure 6 shows an MRI from a patient with a bulging intervertebral
disc. This can be seen as the nucleus pulposus has not completely herniated through the annulus
fibrosis. The annulus fibrosis has weakened to the point that the nucleus pulposus is bulging
posteriorly to compress the spinal cord. In more severe cases of DDD, the annulus fibrosis can
completely tear. When this occurs, rather than simply bulging, the nucleus pulposus completely
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herniates into the spinal canal. Figure 7 shows a complete herniation of the intervertebral disc.
The annulus fibrosis has weakened to the point that it has completely torn, allowing for the
nucleus pulposus to escape into the spinal canal.
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Figure 6: MRI of Midsagittal Lumbar Spine with Bulging Intervertebral Disc
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https://www.mayfieldclinic.com/mc_hope/story_rusty.htm
Figure 7: MRI of Lumbar Spine with Herniated Intervertebral Disc
Research suggests that people may have genetic predisposition to disc herniation
(Ravichandran et al., 2022). In order to understand this, it is important to discuss the central
dogma of molecular biology. The central dogma of molecular biology states that DNA codes for
RNA which codes for protein. DNA is found within the nucleus of cells and contains the genetic
code. This means that DNA codes for the proteins that are responsible for cellular processes.
These proteins serve as enzymes, receptors, and even make up the cytoskeleton of cells. In a
process known as transcription, mRNA is made from DNA by RNA polymerase. This mRNA
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will leave the nucleus and undergo a process known as translation. During translation, a structure
known as a ribosome synthesizes protein from the mRNA transcript. DNA can also undergo
replication. This is a process in which an enzyme known as DNA polymerase makes copies of
the DNA for cell replication. As DNA is double-stranded, an enzyme known as DNA helicase
must separate the two strands prior to this replication. Figure 8 shows this process of
transcription and translation. DNA is organized into units called genes. Humans inherit these
genes from their parents, but the inherited are not identical to the genes of the parents. Gametes,
or germ cells, are the cells involved in sexual reproduction. In order to produce these gametes,
the cells undergo a process known as meiosis. Humans are diploid organisms which means that
they have two copies of each chromosome. Meiosis, however, results in haploid gametes which
means that the gametes only have one copy of each chromosome. The second copy will come
from the other parent’s gamete when sperm fertilizes an egg. During meiosis, specifically in
prophase I, a process known as “crossing over” occurs. This crossing over results in genetic
recombination. Genetic recombination results in variation in the DNA of the offspring. Because
there is variation in the DNA, there will be variation in the proteins. Sometimes, this can lead to
faulty proteins. When these proteins do not function as they should, diseases and pathologies can
arise. One of these pathologies may be compromised intervertebral disc structure. As mentioned
previously, research suggests that individuals may be genetically predisposed to developing
degenerative disc disease. This will be investigated further in this study.
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https://byjus.com/biology/central-dogma-inheritance-mechanism/
Figure 8: Central Dogma of Molecular Biology

In this study, genes for Vitamin D receptor (VDR) and collagen IX will be studied. The
decision to examine these genes was based on research of candidate genes that could be
correlated with degenerative disc disease.
Vitamin D Receptor (VDR)
The vitamin D receptor is a steroid nuclear receptor which is known to be associated with
the mineralization and remodeling of bones. The vitamin D receptor is known to be involved in
bone mineralization through modulating calcium absorption (Xue & Fleet, 2009). The vitamin D
receptor is not only involved in calcium homeostasis, but it also has immunomodulatory
properties as well (Ayuso et al., 2017). The VDR gene can be found on chromosome 12 and has
two polymorphisms: TaqI and FokI. A polymorphism is defined as a variation within the DNA
sequence. Polymorphisms often result from mutations but may also arise from natural variation.
According to Chan et al. (2006), it was first thought to be associated with degenerative disc
disease after a study involving monozygotic twins with these gene polymorphisms. Monozygotic
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twins are identical twins. Identical twins arise when a single fertilized embryo splits into two
embryos. Both of those embryos then develop into individual people. Conversely, dizygotic
twins are fraternal twins. Dizygotic twins arise when two separate eggs are fertilized by two
different sperm in two separate fertilization events. These embryos will then develop into two
separate individuals. In this twin study, it was found that sets of monozygotic twins with the
heterozygous TaqI phenotype had higher instances of disc herniation, disc degeneration, and
multilevel disc disease than those with the homozygous dominant phenotype (Chan et. al., 2006).
Because of this, it is thought that carrying the heterozygous form of the TaqI polymorphism
increases risk of degenerative disc disease. The TaqI polymorphism is found in exon 9 (Bagheri
et al., 2013). This correlation was observed in Japanese, Chinese, African, and Caucasian
populations. A theory as to why this gene could be involved in disc degeneration is because
Vitamin D plays a role in sulphate metabolism. This is relevant because the extent to which the
vitamin D receptor is being expressed can affect sulphation of glycosaminoglycans (GAGs)
during proteoglycan synthesis which impacts the structural integrity of the extracellular matrix
(ECM) of the discs of the spine (Chan et. al., 2006). Specifically, a reduction of sulphation of the
glycosaminoglycans may affect the vitamin D receptor’s function which would lead to a
compromised structural integrity of the extracellular matrix.
Collagen IX
Genes coding for collagen IX will also be studied. The role of collagen IX in
intervertebral discs is not completely known, but due to its increased flexibility compared to
other types of collagen, it is thought to connect collagen II with other components of the
cartilage which is important to the integrity of the tissue. While there are three genes that code
for collagen IX, Chan et al. (2006) only mention that COL9A2 and COL9A3 mutations may be
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correlated with DDD. They note that a Q326W substitution in the COL9A2 gene and an R103W
substitution in the COL9A3 gene could be correlated with disc herniation. However, the Q326W
and R103W substitutions were only seen in 4% and 24% of patients respectively (Chan et al.,
2006). These letters refer to amino acids in the primary structure of proteins. In both of these
genes, an amino acid is being substituted for a tryptophan. This presence of tryptophan in the
helical region, due to its large size and hydrophobic nature, is thought to interfere with the
interactions between collagen IX and the other ECM molecules and collagen fibrils within the
intervertebral discs. The COL9A2 gene will be studied specifically. This gene can be found on
exon 19 of chromosome 1.
Cadaver donors were used for genetic analysis in this study. Cadaver donors were used
for a few reasons. First, individual and institutional review board permission was not necessary
to obtain. As these cadavers came from Wright State University Boonshoft School of Medicine,
consent from the director of the anatomical gift program was obtained. However, in live humans,
consent would need to be obtained from every individual. Also, the risk for encountering disease
was much lower in cadavers due to the embalming fluid killing any pathogens in the body. This
embalming fluid is essential not only to killing any pathogens but preserving the body as well.
Without this embalming fluid, the body would rapidly decay. The embalming fluid is made up of
methanol, formaldehyde, and phenol. Because cadavers are embalmed with these chemicals,
there was concern that the embalming fluid would damage the DNA to the extent that it would
not be possible to extract sufficient DNA for amplification by polymerase chain reaction (PCR).
One of the goals of this study was to determine if extracting amplifiable DNA from embalmed
tissue is possible. According to Gielda and Rigg (2017), it is possible. They collected tissues
from multiple cadavers that had been embalmed for 1-3 years. Tissues from the cerebellum, the
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cerebral cortex, the heart, and bone were used in their study. The concern with doing genetic
analysis on cadaver tissue is that the formaldehyde and phenol of the embalming fluid would
induce cross-linking of the proteins within the DNA to the extent that PCR and sequencing could
not be performed. However, Gielda and Rigg (2017) were able to develop a procedure that
removed cross-linked proteins from the DNA so sufficient DNA could be extracted. This
procedure was most successful on cerebellar tissue with 463.35 ng/µL ± 316.98 ng/µL of DNA
being extracted. The DNA extracted from the cerebellum had an A260/A280 ratio of 1.90 ± 0.09.
Their study showed that extraction of the DNA from embalmed tissue is possible.
The goal of this study is to determine whether polymorphisms within the VDR or
COL9A2 genes can be correlated to increased susceptibility of developing degenerative disc
disease. This is important as DDD and the associated intervertebral disc herniation and bulging
is extremely prevalent in the United States and around the world. Learning more about the
genetic aspects of this condition can help clinicians predict if their patients may be more
susceptible to herniating a disc. This could also be used to further develop gene therapy to treat
or prevent DDD.

METHODS
I.

DISSECTION

As mentioned previously, the cadaver donors in this study came from Wright State
University Boonshoft School of Medicine. These donors very generously bequeathed their
bodies to the Wright State University Boonshoft School of Medicine Anatomical Gift Program
for education and research. Bellarmine University is one of the few institutions in the country
that offers a gross anatomy course for undergraduate students. Bellarmine University often
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partners with Wright State University Boonshoft School of Medicine to obtain cadavers for
dissection in the course. These cadavers that were loaned to Bellarmine University for the gross
anatomy course were used in this study. However, prior to dissection, permission to proceed with
this study was obtained from Mr. Rodney Guthrie, director of the Anatomical Gift Program at
Wright State University Boonshoft School of Medicine.
Cadaver dissection was done in two parts. Tissue samples were excised from four distinct
regions of three female cadavers by gross dissection. The four regions were the grey matter of
the cerebellum, the grey matter of the medial occipital lobe cortex, the parotid gland, and the
genioglossus muscle. Images of these regions can be found in Figures 9, 10, and 11. Cerebellar
and cerebral tissue samples were taken due to the success of Dr. Gielda and Ms. Rigg’s research
(Gielda & Rigg, 2017). They were able to extract DNA of high concentration and purity from
these tissues. The parotid gland was chosen due to it being epithelial tissue. It was hypothesized
that epithelial tissue would provide easy access and a high tissue yield. Epithelial tissue is
comprised of many layers of cells. Because of this, there would theoretically be many nuclei
within epithelial tissue samples. It was hypothesized that this increased number of nuclei would
result in a high DNA concentration. The genioglossus was selected due to it being skeletal
muscle. It was hypothesized that because skeletal muscle cells are multinucleated, a higher
concentration of DNA could be extracted.
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https://www.kenhub.com/en/library/anatomy/midsagittal-section-of-the-brain
Figure 9: Midsagittal View of the Right Hemisphere of the Brain

https://study.com/academy/lesson/genioglossus-muscle-origin-action-insertion.html
Figure 10: Parasagittal View of the Tongue
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https://www.mskcc.org/cancer-care/types/salivary-gland/salivary-glands-anatomy
Figure 11: Lateral View of Right Face

After the tissue samples were excised and stored in formalin at room temperature, the
cadaver spines were dissected. Using electric saws and hacksaws, the cadavers were cut in the
transverse plane at the thoracic spine. Then, the lower portions of the cadavers were cut in the
midsagittal plane starting at the groin. This allowed for visualization of the spinal canal and the
intervertebral discs.
II.

DNA EXTRACTION

DNA extraction was performed using the DNeasy Blood & Tissue Kit manufactured by
Qiagen (9300 Germantown Rd, Germantown, MD, 20874, USA). There were two phases of
this extraction: lysis and elution. Lysis is defined as the breakdown of a cell due to a ruptured
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plasma membrane. Elution is defined as the separation of an absorbed material from a membrane
through a process of washing. These two phases were performed on consecutive days. Because
the tissue was embalmed and fixed in formalin, extra steps had to be taken prior to lysis. Each
tissue sample was washed twice in PBS via pipetting to remove the fixative. Then each tissue
sample was cut into pieces weighing less than 25 mg to work with. To begin the lysis procedure,
each tissue sample was frozen in liquid nitrogen and ground up. The tissues were then lysed
overnight in a 56°C incubator with proteinase K from the DNeasy Blood & Tissue Kit.
After the lysis was complete on the following morning, each sample was washed in a series
of buffers from the DNeasy Blood & Tissue Kit using spin columns. After the washes were
completed, elution buffer AE from the DNeasy Blood & Tissue Kit was added to the spin
columns, and DNA was collected via centrifugation at 8,000 rpm. Figures 12 and 13 show the
elution buffer being added and centrifugation respectively. The centrifuge used in this study was
a conventional table-top microcentrifuge. Each sample was then assessed for concentration and
purity through the use of a Nanodrop spectrophotometer. Figure 14 shows the NanoVue Plus
Spectrophotometer from GE Healthcare (9900 West Innovation Dr, Wauwatosa, WI, 53226,
USA) which was used in this study. A DNA sample is placed on the sensor of the Nanodrop
spectrophotometer, and the spectrophotometer provides a concentration (ng/µL) and purity
(A260/A280 ratio). The A260/A280 ratio indicates how much DNA is present in the sample
relative to proteins and other impurities. DNA absorbs light at a wavelength of 260 nm while
proteins absorb light at a wavelength of 280 nm. A relatively pure DNA sample will have an
A260/A280 ratio of 1.8 to 1.9. Prior to using the Nanodrop spectrophotometer, it must be
blanked. This is done so the spectrophotometer can zero out any background readings. The
elution buffer AE was used to blank the Nanodrop spectrophotometer.
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Figure 12: Pipetting Elution Buffer AE into Spin Columns

Figure 13: Centrifugation of Spin Columns with Elution Buffer AE to Elute DNA
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Figure 14: NanoVue Plus Spectrophotometer

III.

POLYMERASE CHAIN REACTION (PCR)

In order to analyze extracted DNA, it must be amplified. PCR is a powerful technique used to
do this. PCR was performed using the Apex Hot Start Master Mix from Genesee Scientific (900
Vernon Way, El Cajon, CA, 92020, USA). The Apex Hot Start Master Mix contained taq DNA
polymerase, MgCl2, blue dye for visualization on an agarose gel, and ammonium buffer that
promotes high amplification, yield, and specificity. The MgCl2 is vital to a successful PCR
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reaction as Mg2+ serves as a cofactor for DNA polymerase. Each PCR reaction was composed of
the Apex master mix, forward and reverse DNA primers, deionized water, and template DNA
that was extracted using the DNeasy Blood and Tissue Kit. Each PCR reaction had a total
volume of 25 µL. Each of these PCR reactions was placed in a MJ Mini Personal Thermal
Cycler from Bio-Rad (1000 Alfred Nobel Dr, Hercules, CA, 94547, USA) and amplified for 40
cycles. Figure 15 shows the thermocycler used in this study.

Figure 15: MJ Mini Personal Thermal Cycler from Bio-Rad

PCR has three phases per cycle: denaturation, annealing, and extension. In the denaturation
phase, the two strands of the template DNA are separated through the breaking of hydrogen
bonds at a high temperature. The second phase is annealing. Once the DNA is denatured, the
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temperature is lowered, so the primers can form hydrogen bonds with the template DNA and
bind to it. The third phase is extension. Once the primers have annealed to the template DNA, the
temperature is again increased, so taq DNA polymerase can bind to the primers and add
deoxynucleoside triphosphates (dNTPs) to the 3’ end of the primers to extend the DNA strand
copy. Figure 16 shows this process. In this study, the thermocycler first increased temperature to
95 °C for 15 minutes. Then to begin the cycles, the denaturation phase was 95 °C for 30 seconds.
The annealing phase was 55 °C for 30 seconds. The extension phase was 72 °C for 1 minute.
These three phases were repeated 39 more times. After the 40th cycle, the thermocycler stayed at
72 °C for 5 minutes to allow for the completion of replication for any partial copies. Then, the
thermocycler remained at 10 °C to maintain PCR product integrity until the tubes were removed
from the thermocycler.

https://en.wikipedia.org/wiki/Polymerase_chain_reaction
Figure 16: Polymerase Chain Reaction
Each set of primers had to be optimized to determine the optimal DNA concentration to
produce the best bands for each set of primers. In performing this optimization, multiple PCR
reactions were run with different amounts of template DNA in each tube. The concentration of
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the tube with the strongest band was used for subsequent reactions. Each reaction was run in
duplicate to counteract any erroneous mutations that may occur during PCR.
The primers used to amplify the VDR gene are as follows:
Forward: 5’ CAG AGC ATG GAC AGG GAG CAAG 3’
Reverse: 5’ GCA ACT CCT CAT GGC TGA GGT CTCA 3’
The VDR gene primer sequences were taken from a previous student at Bellarmine
University, Sharon Kemp (2011).
The primers used to amplify the COL9A2 gene are as follows:
Forward: 5’ AAG GAC TGT GTT CCG TGA CC 3’
Reverse: 5’ TGG CCA AAG. AGA AGG CTA GA 3’
The COL9A2 gene primers were designed using the internet program, Primer3.
In order to visualize the amplified DNA from PCR, agarose gel electrophorese was
performed. A 1% agarose gel was made using agarose, 50X TAE buffer, Apex Safe DNA Gel
Stain, and deionized water. Figure 17 shows the gel solidifying. Once the gel had solidified and
the PCR reaction was completed, 10 µL of a molecular weight standard and 25 µL of each PCR
reaction were pipetted into the gel. The electrophoresis was run for 40 minutes at 90 V. Upon
completion of the gel electrophoresis, the bands were visualized using a ChemiDoc Imaging
System from Bio-Rad. Figure 18 shows this ChemiDoc imaging system at Bellarmine
University. DNA bands were excised from the agarose gel and isolated for sequencing using the
Zymoclean Gel DNA Recovery Kit from Zymo Research (17062 Murphy Ave., Irvine, CA,
92614, USA). Figure 19 shows the DNA bands being excised from the agarose gel.
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Figure 17: Making the 1% Agarose Gel for Electrophoresis

Figure 18: ChemiDoc Imaging System from Bio-Rad
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Figure 19: Excising DNA Bands from Agarose Gel

IV.

BIOINFORMATIC ANALYSIS

After the DNA was excised from the agarose gel, it was taken to Eurofins Genomics LLC
(12701 Plantside Dr., Louisville, KY, 40299) for sequencing. Because these samples were
associated with Bellarmine University, each sample cost five dollars to sequence. The sequences
were obtained in one business day. Each sample contained 6 µL of template DNA and 4 µL of
forward primer. Once the sequencing was complete, the results were viewed on a chromatogram.
Figure 20 shows the chromatogram from the COL9A2 sequence of donor 1. The FASTA
sequences were taken from the chromatogram and compared with published National Center for
Biotechnology Information (NCBI) sequences using BLASTn analysis. FASTA sequences are
the text-based format of the DNA sequences. BLAST is a free internet program from NCBI.
BLAST, or basic local alignment search tool, allows researchers to align their sequences with
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those that have been previously published in the NCBI database. Because of this, potential
mutations can be identified. There are different types of BLAST searches. A BLASTn analysis,
specifically, aligns nucleotides. Unfortunately, only the COL9A2 sequence from cadaver 1
showed any significant similarity to published sequences. Therefore, the QIAquick PCR and Gel
Cleanup Kit from Qiagen was used in an attempt to further remove any impurities from the
excised DNA that may be obstructing the sequence. In addition, another set of PCR reactions
was performed and rather than run the DNA on a 1% agarose gel and excise the bands, the
QIAquick PCR and Gel Cleanup Kit was used immediately to purify the PCR product. The
excised DNA and the additional PCR products were sent to Eurofins Genomics for sequencing.

Figure 20: Donor 1 COL9A2 Chromatogram

RESULTS
I.

DONOR 1 DISSECTION
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Figure 21: Midsagittal View of Donor 1 Lumbar Spine

Donor 1 was an 87-year-old female who passed away on December 21, 2019. Her cause
of death was ovarian carcinoma with hepatic, pelvic, and abdominal metastasis. Figure 21 shows
the lumbar spine dissection of donor 1 from a midsagittal view. The lumbar spine had been cut in
the midsagittal plane to get this view of the medial portion of the spine. The thick dark masses on
the anterior spine are the vertebral bodies. Between these vertebral bodies are thin white masses.
These are the intervertebral discs. In this image, posterior disc bulging can be seen very clearly.
The intervertebral discs are bulging into the spinal canal where the spinal nerves are located. The
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spinal cord ends at L3 and becomes spinal nerves at the cauda equina. This donor shows clear
evidence of degenerative disc disease.

II.

DONOR 2 DISSECTION
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Figure 22: Anterior View of Donor 2 Lumbar Spine

Donor 2 was a 90-year-old female who died on December 17, 2019. Her cause of death
was not listed. Her anatomy displayed interesting pathology from the anterior view of the spine.
This can be seen in Figure 22. There is clear evidence of lumbar scoliosis. Scoliosis is a
condition in which the spine curves laterally. While scoliosis was not directly a subject of this
study, it was an interesting spine-related pathology to observe. Figure 23 shows the normal
curvature of the spine. There should normally be anterior and posterior curving, but lateral
curving is abnormal.
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https://www.neurologyneeds.com/neuroanatomy/spine/vertebral-column/
Figure 23: Anterior and Lateral View of Normal Spine Curvature
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Figure 24: Midsagittal View of Donor 2 Lumbar Spine

After a transverse cut was made at the thoracic spine, an electric saw was used to make a
midsagittal cut inferiorly. Figure 24 shows this dissection. Similar to donor 1, donor 2 shows
posterior disc bulging into the spinal canal. This bulging could have potentially compressed the
spinal cord or spinal nerves resulting in severe pain. Another interesting pathology can be seen in
donor 2 as well. The intervertebral discs seem to be much thinner than those of donor 1. This is
evidence of intervertebral disc desiccation. This means that the discs have dried out. This disc
desiccation is a very common feature of degenerative disc disease.
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III.

CADAVER 3 DISSECTION
T12

Superior

L1

Spinal
Cord
Cauda
Equina

L2

Bulging
Intervertebral Discs

Bulging
Intervertebral Discs

Posterior

Anterior

Spinous
Process

Intervertebral
Disc Desiccation
L3

Intervertebral Disc

L4
L5

Sacrum
Inferior

Figure 25: Midsagittal View of Donor 3 Lumbar Spine

Donor 3 was an 88-year-old female who died on November 25, 2019. Her cause of death
was acute chronic hypercapnic respiratory failure, acute kidney injury, acute congestive heart
failure, hypertension, coronary artery disease, diabetes mellites II, and hypothyroidism. Similar
to the others, cadaver 3 displays clear evidence of degenerative disc disease. This can be clearly
seen in Figure 25. In fact, cadaver 3 appears to have the most severe case of DDD. Very
prominent posterior disc bulging can be observed as the discs bulge into the spinal canal. The
most severe bulging seems to be at the L1-L2 and L2-L3 intervertebral discs. These discs may
have been compressing the spinal nerves which could result in pain. There is observable
evidence of anterior disc bulging as well. Evidence of disc desiccation can be observed in the
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L1-L2, L2-L3, and L4-L5 discs. In addition, the L3-L4 disc is abnormally enlarged. There seems
to be abnormal coloration to the T12 vertebral body as well. While a physician diagnosis would
be needed for confirmation, it appears as if this may be evidence of Pott’s disease. Figure 26
shows signs of Pott’s disease in the L1 and L2 vertebral bodies. This is an abnormal coloration of
the vertebral body. Pott’s disease is a form of tuberculosis that is observed in the spine
(Viswanathan & Subramanian, 2022). Fat can also infiltrate the vertebral body. There also
appears to be some evidence of lordosis. Lordosis is characterized by an abnormally pronounced
anterior curve of the lumbar spine.
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https://openinfectiousdiseasesjournal.com/VOLUME/10/PAGE/101/FULLTEXT/
Figure 26: MRI Displaying L1-L2 Pott’s Disease
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Figure 27: Midsagittal View of Cadaver 3 Lumbar Spine with Hardware

Upon further cleaning of the spine, surgical hardware could be observed in the posterior
portion of the sacrum. This hardware is clearly visible in Figure 27. Perhaps this hardware served
to stabilize an unstable pelvis due to a fracture. While the reason for this hardware is unknown, it
was interesting to find.
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IV.

DNA EXTRACTION

As mentioned previously, tissue samples were taken from the cerebella, occipital lobes,
parotid glands, and genioglossus muscles of each donor. Each of these tissue samples was cut
into smaller pieces as the DNeasy Blood and Tissue Kit required tissue samples to be less than or
equal to 25 mg. The masses of each tissue sample used for DNA extraction can be found in
Table 1.
Table 1: Mass of Tissue Samples Used for DNA Extraction
Sample
Cadaver 1 Cerebellar Tissue 1
Cadaver 1 Cerebral Tissue 1
Cadaver 1 Parotid Tissue 1
Cadaver 1 Genioglossus Tissue 1
Cadaver 2 Cerebellar Tissue 1
Cadaver 2 Cerebral Tissue 1
Cadaver 2 Parotid Tissue 1
Cadaver 2 Genioglossus Tissue 1
Cadaver 3 Cerebellar Tissue 1
Cadaver 3 Cerebral Tissue 1
Cadaver 3 Parotid Tissue 1
Cadaver 3 Genioglossus Tissue 1
Cadaver 1 Cerebellar Tissue 2
Cadaver 1 Cerebral Tissue 2
Cadaver 1 Parotid Tissue 2
Cadaver 1 Genioglossus Tissue 2
Cadaver 2 Cerebellar Tissue 2
Cadaver 2 Cerebral Tissue 2
Cadaver 2 Parotid Tissue 2
Cadaver 2 Genioglossus Tissue 2
Cadaver 3 Cerebellar Tissue 2
Cadaver 3 Cerebral Tissue 2
Cadaver 3 Parotid Tissue 2
Cadaver 3 Genioglossus Tissue 2
Cadaver 1 Cerebellar Tissue 3
Cadaver 1 Cerebral Tissue 3
Cadaver 1 Parotid Tissue 3
Cadaver 1 Genioglossus Tissue 3

Mass (mg)
20.1
21.8
19.6
22.2
18.8
23.8
19.9
17.6
21.0
20.9
22.6
21.1
18.3
20.5
21.8
22.6
20.8
20.7
18.8
19.0
20.4
20.7
18.7
20.3
22.5
21.9
22.9
19.7

Lynn 40
Cadaver 2 Cerebellar Tissue 3
Cadaver 2 Cerebral Tissue 3
Cadaver 2 Parotid Tissue 3
Cadaver 2 Genioglossus Tissue 3
Cadaver 3 Cerebellar Tissue 3
Cadaver 3 Cerebral Tissue 3
Cadaver 3 Parotid Tissue 3
Cadaver 3 Genioglossus Tissue 3

18.5
21.6
18.6
18.6
18.1
20.7
23.4
24.4

Once DNA extraction was performed, the isolated DNA was analyzed for concentration
and purity through the use of a Nanodrop spectrophotometer. The concentration was measured in
ng/µL and purity was measured through the A260/A280 ratio. This A260/A280 ratio is
indicative of purity as it shows how much DNA is present in the sample relative to protein
through the use of absorbance. DNA absorbs light at 260 nm while proteins absorb light at 280
nm. A pure DNA sample should have an A260/A280 ratio between 1.8 and 1.9. Contaminants
such as proteins that absorb at 280 nm will lower that ratio which indicates a less pure DNA
sample. The concentration and purity of the extracted DNA from each sample is shown in Table
2.
Table 2: Concentration and Purity of DNA Extracted from Tissue Samples
Sample
Cadaver 1 Cerebellar Tissue 1
Cadaver 1 Cerebral Tissue 1
Cadaver 1 Parotid Tissue 1
Cadaver 1 Genioglossus Tissue 1
Cadaver 2 Cerebellar Tissue 1
Cadaver 2 Cerebral Tissue 1
Cadaver 2 Parotid Tissue 1
Cadaver 2 Genioglossus Tissue 1
Cadaver 3 Cerebellar Tissue 1
Cadaver 3 Cerebral Tissue 1
Cadaver 2 Parotid Tissue 1
Cadaver 3 Genioglossus Tissue 1
Cadaver 1 Cerebellar Tissue 2 Elution 1

Concentration
(ng/µL)
19.6
11.7
24.3
19.4
6.2
15.6
22.3
2.2
29.9
10.6
21.2
10.9
38.7

A260/A280
2.09
2.40
1.76
1.93
5.37
2.14
1.98
-3.12
2.05
2.34
3.28
2.53
1.55
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Cadaver 1 Cerebellar Tissue 2 Elution 2
Cadaver 1 Cerebral Tissue 2 Elution 1
Cadaver 1 Cerebral Tissue 2 Elution 2
Cadaver 1 Parotid Tissue 2 Elution 1
Cadaver 1 Parotid Tissue 2 Elution 2
Cadaver 1 Genioglossus Tissue 2 Elution 1
Cadaver 1 Genioglossus Tissue 2 Elution 2
Cadaver 2 Cerebellar Tissue 2 Elution 1
Cadaver 2 Cerebellar Tissue 2 Elution 2
Cadaver 2 Cerebral Tissue 2 Elution 1
Cadaver 2 Cerebral Tissue 2 Elution 2
Cadaver 2 Parotid Tissue 2 Elution 1
Cadaver 2 Parotid Tissue 2 Elution 2
Cadaver 2 Genioglossus Tissue 2 Elution 1
Cadaver 2 Genioglossus Tissue 2 Elution 2
Cadaver 3 Cerebellar Tissue 2 Elution 1
Cadaver 3 Cerebellar Tissue 2 Elution 2
Cadaver 3 Cerebral Tissue 2 Elution 1
Cadaver 3 Cerebral Tissue 2 Elution 1
Cadaver 3 Parotid Tissue 2 Elution 1
Cadaver 3 Parotid Tissue 2 Elution 2
Cadaver 3 Genioglossus Tissue 2 Elution 1
Cadaver 3 Genioglossus Tissue 2 Elution 2
Cadaver 1 Cerebellar Tissue 3 Elution 1
Cadaver 1 Cerebellar Tissue 3 Elution 2
Cadaver 1 Cerebral Tissue 3 Elution 1
Cadaver 1 Cerebral Tissue 3 Elution 2
Cadaver 1 Parotid Tissue 3 Elution 1
Cadaver 1 Parotid Tissue 3 Elution 2
Cadaver 1 Genioglossus Tissue 3 Elution 1
Cadaver 1 Genioglossus Tissue 3 Elution 2
Cadaver 2 Cerebellar Tissue 3 Elution 1
Cadaver 2 Cerebellar Tissue 3 Elution 2
Cadaver 2 Cerebral Tissue 3 Elution 1
Cadaver 2 Cerebral Tissue 3 Elution 2
Cadaver 2 Parotid Tissue 3 Elution 1
Cadaver 2 Parotid Tissue 3 Elution 2
Cadaver 2 Genioglossus Tissue 3 Elution 1
Cadaver 2 Genioglossus Tissue 3 Elution 2
Cadaver 3 Cerebellar Tissue 3 Elution 1
Cadaver 3 Cerebellar Tissue 3 Elution 2
Cadaver 3 Cerebral Tissue 3 Elution 1
Cadaver 3 Cerebral Tissue 3 Elution 1
Cadaver 3 Parotid Tissue 3 Elution 1
Cadaver 3 Parotid Tissue 3 Elution 2

15.4
22.9
11.6
44.2
19.8
34.9
19.8
59.6
17.8
25.2
8.1
57.0
20.6
18.6
18.7
53.5
28.5
30.0
11.9
40.4
34.1
23.0
11.2
36.5
24.5
20.5
11.2
33.5
36.5
26.0
23.5
44.5
15.1
30.5
9.4
40.0
30.0
20.0
29.0
42.5
16.5
23.5
10.8
32.0
60.0

1.53
1.64
1.42
1.53
1.42
1.58
1.43
1.65
1.48
1.66
1.64
1.39
1.69
1.49
1.42
1.68
1.28
1.57
1.56
1.45
1.40
1.58
1.33
1.698
1.788
1.647
2.045
1.523
1.553
1.576
1.649
1.712
1.624
1.794
1.731
1.667
1.765
1.724
1.758
1.735
1.634
1.673
1.680
1.641
1.667
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Cadaver 3 Genioglossus Tissue 2 Elution 1
Cadaver 3 Genioglossus Tissue 2 Elution 2

22.5
16.1

1.642
1.602

After analyzing the DNA extraction results, one sample for each donor was chosen for
PCR amplification. Only one sample per donor was necessary as every tissue in the body
contains the same genomic DNA. Different tissue samples were taken to determine if one region
of the body would yield DNA of higher concentration and purity. For cadaver 1, Cerebellar
Tissue 3 Elution 2 was selected for PCR as it yielded a concentration of 24.5 ng/µL and an
A260/A280 ratio of 1.788. For cadaver 2, Cerebral Tissue 3 Elution 1 was selected for PCR as it
yielded a concentration of 30.5 ng/µL and an A260/A280 ratio of 1.794. For cadaver 3,
Cerebellar Tissue 3 Elution 1 was selected for PCR as it yielded a concentration of 42.5 ng/µL
and an A260/A280 ratio of 1.735. Each of these samples had decent concentration and purity.
This is consistent with research performed by Gielda and Rigg. They were most successful in
extracting DNA of high concentration and purity from cerebellar tissue. For this study, purity
was more important than concentration as higher volumes could be used to make the PCR
reactions if concentration was low. After primer optimization, the optimal template DNA
concentration was near 50 ng for both VDR and COL9A2. Purity is extremely important because
a sample with contaminants will be unable to be sequenced.
An ANOVA statistic test was performed to determine if the concentrations of DNA
extracted from each tissue were significantly different than the concentrations of DNA extracted
from the other tissues. The mean concentration from the cerebellar tissue was 29.92 ng/µL. The
mean concentration from the cerebral tissue was 16.9 ng/µL. The mean concentration from the
parotid gland tissue was 34.39 ng/µL. The mean concentration from the genioglossus muscle
tissue was 19.72. The p-value from the ANOVA test was 1.725x10-4. This implies that there was
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significant evidence to reject the null hypothesis that the mean concentrations for each tissue
were the same.
An ANOVA statistic test was also performed to determine if the purities of DNA
extracted from each tissue were significantly different than the purities of DNA extracted from
the other tissues. The mean A260/A280 ratio from the cerebellar tissue was 1.925. The mean
A260/A280 ratio from the cerebral tissue was 1.796. The mean A260/A280 ratio from the
parotid gland tissue was 1.714. The mean A260/A280 ratio from the genioglossus muscle tissue
was 1.340. The p-value from the ANOVA test was 0.275. This implies that there was not
significant evidence to reject the null hypothesis that the mean A260/A280 ratios for each tissue
were the same.

V.

POLYMERASE CHAIN REACTION (PCR)

After each PCR reaction was completed, the results were visualized on a 1% agarose gel.
Agarose gel electrophoresis is a technique that is performed to separate DNA fragments based on
molecular weight. DNA is negatively charged, so when it is put in an electric field, it will
migrate towards the positive anode. The smaller pieces of DNA will move faster through the gel,
so the larger DNA fragments will be seen towards the top of the gel while the smaller DNA
fragments will be seen towards the bottom. This was done to ensure that the PCR product was
the desired gene. Each PCR product should have a specific size due to the chosen primers. The
VDR gene product should have been 7500 base pairs in size while the COL9A2 gene product
should have been 6840 base pairs in size. This could be verified based on the DNA fragment
position in the gel.
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Figure 28: VDR and COL9A2 Agarose Gel Electrophoresis
Figure 28 contains the VDR and COL9A2 PCR products for each donor. There are two
lanes per cadaver as each reaction was run in duplicate to counteract any erroneous mutations
resulting from PCR. The primers were optimized prior to these PCR reactions. The optimal
template concentration for VDR was observed to be 13.5 ng. Therefore, 12.25 ng were used for
cadaver 1, 15.25 ng were used for cadaver 2, and 10.625 ng were used for cadaver 3. The
optimal template concentration for COL9A2 was observed to be 50 ng. Therefore, 49 ng were
used for cadaver 1, 45.75 ng were used for cadaver 2, and 53.125 ng were used for cadaver 3.
However, when performing the subsequent PCR reactions, VDR bands were not present as seen
in Figure 13. However, the COL9A2 bands with 50 ng were strong, so these bands were excised
from the gel and purified using the Zymoclean Gel DNA Recovery Kit for sequencing.
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Figure 29: VDR Agarose Gel Electrophoresis
Because bands were not visible after PCR with 12.25 ng for cadaver 1, 15.25 ng for
cadaver 2, and 10.625 ng for cadaver 3, the 13.5 ng VDR optimization must have been
erroneous. Because of this, the concentration was increased in an attempt to create stronger
bands. The concentration was increased to 52.675 ng for cadaver 1, 53.375 ng for cadaver 2 ,and
53.125 ng for cadaver 3. As seen in Figure 29, the bands were much stronger as a result. These
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VDR bands were excised from the gel and purified using the Zymoclean Gel DNA Recovery Kit
for sequencing.

VI.

SEQUENCING AND BIOINFORMATIC ANALYSIS

Unfortunately, the sequencing results were poor. Upon examining the sequences on a
chromatogram, there was a substantial amount of overlap in the peaks with significant baseline
noise. This resulted in unclear sequences. There was a significant number of “Ns,” or unknown
bases, in each sequence. When performing BLASTn analysis, only the COL9A2 sequence from
donor 1 showed any significant similarity to a published sequence of the National Center for
Biotechnology Information (NCBI). Therefore, this was the only cadaver gene sequence that
could be aligned with a published sequence. In an attempt to improve sequencing results, the
DNA that was excised from the agarose gel was further purified by using the QIAquick PCR and
Gel Cleanup Kit. This DNA was then sent to Eurofins Genomics again to be re-sequenced. In
addition, another set of PCR reactions was performed. However, rather than run the PCR
products on a gel, the PCR product purification protocol from the QIAquick PCR and Gel
Cleanup Kit was used immediately on the PCR products. This purified DNA was then sent to
Eurofins Genomics for sequencing as well. Unfortunately, these attempts at obtaining better
sequencing results were unsuccessful. The COL9A2 sequence from cadaver 1 was, once again,
able to be aligned with the published COL9A2 sequence via BLASTn analysis. Similarities were
found in BLASTn analysis of the VDR sequences from donors 2 and 3 and the COL9A2
sequence from donor 3, but they did not align with their respective target genes.
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Figure 30: Cadaver 1 COL9A2 Sequence Alignment
Figure 30 shows the alignment of the COL9A2 sequence from donor 1 to the published
COL9A2 sequence. The score of this alignment was 141 bits. The bit score is a statistical value
that measures sequence similarity. A higher bit score indicates a more significant match. The
identity score was 100% which indicates that the DNA query and subject sequences matched
perfectly without any base misalignments. The query sequence represents the COL9A2 sequence
from donor 1 while the subject sequence represents the NCBI published COL9A2 sequence.
Because the identity score was 100% and there were no base misalignments, the Q326W
substitution was not observed in this donor. Unfortunately, the other sequences were unable to be
analyzed.
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CONCLUSION
This was a rather ambitious study with a few different goals. Unfortunately, not all of
these goals were achieved, but this study did yield valuable information. The first part of this
study was to determine if it is possible to extract amplifiable DNA from tissue that has been
embalmed. These cadavers were lent to Bellarmine University by Wright State University
Boonshoft School of Medicine. Their embalming fluid contains methanol, formaldehyde, and
phenol. These chemicals, specifically formaldehyde, can be a hinderance to amplifiable DNA
extraction. Formalin fixation is known to induce cross-linking between DNA and proteins. This
would reduce the quality of DNA that could be extracted. This cross-linking would hinder PCR
amplification. One goal of this study was to determine if that cross-linking could be counteracted
to successfully amplify DNA through PCR. Gielda and Rigg (2017) published an article
suggesting that it is possible to extract DNA and amplify it through PCR for study. They also
demonstrated that cerebellar and cerebral tissue yielded the DNA of highest concentration and
purity. This was the second part of this study. Tissue samples were taken from grey matter of the
cerebellum, grey matter of the medial occipital lobe cortex, the parotid gland, and genioglossus
muscle. This study aimed to determine if one of these tissues yielded DNA of significantly
higher concentration and purity than the others. The ability to extract amplifiable DNA from
embalmed tissue was confirmed through agarose gel electrophoresis. The amplified DNA from
PCR is clearly visible in Figures 28 and 29. It was also determined that some tissues yielded
significantly higher DNA concentrations than others. An ANOVA statistical test was performed
to determine this. The p-value of 1.725x10-4 indicated that there was significant evidence to
reject the null hypothesis that the mean concentrations for each tissue were the same. The mean
concentrations from cerebellar tissue and parotid gland tissue were much higher than those from
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cerebral tissue and genioglossus muscle tissue. The mean DNA concentration from the parotid
gland was actually the highest. A second ANOVA statistical test was performed to determine if
one tissue yielded DNA of significantly higher purity compared to the other tissues. The p-value
of 0.275 indicated that there was not significant evidence to reject the null hypothesis that the
mean A260/A280 ratios for each tissue were the same. The tissue DNA concentrations were
significantly different, but the purities were not.
The third part of this study aimed to use the amplified DNA from the embalmed cadaver
tissue to correlate the VDR TaqI polymorphism and COL9A2 Q326W substitution to increased
susceptibility to degenerative disc disease. As seen in Figures 21, 22, 24, 25, and 27, each donor
showed significant evidence of degenerative disc disease. Unfortunately, sequencing results were
too poor to make any correlations between these polymorphisms and susceptibility to
degenerative disc disease. The COL9A2 chromatogram from donor 1 yielded the only sequence
of any quality. The other chromatograms showed substantial baseline noise and overlap between
peaks which reduced the quality of the sequences. Perhaps there may have still been residual
impurities such as protein or agarose within these DNA samples that could have impeded
accurate sequencing. Only the COL9A2 PCR product from donor 1 showed any significant
similarity to the target gene through BLASTn analysis. While this sequence did align with a
portion of the NCBI published COL9A2 gene sequence, no misalignments were present meaning
that the Q326W could not observed in this particular specimen. Because no other sequence was
able to be aligned with the published sequences of the target genes, the VDR TaqI polymorphism
and COL9A2 Q326W substitution could not be correlated to an increased susceptibility to
degenerative disc disease based on the data generated in this study. This was, however, a
preliminary study. Even if these polymorphisms within the VDR and COL9A2 genes had been
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observed in these three donors, no significant conclusions could have been drawn due to the
small sample size. In the future, this study can be continued with the examination of more gene
polymorphisms in more donors. Perhaps this study could be expanded into live humans as well.

Lynn 51
ACKNOWLEDGEMENTS
I would like to thank my advisor Dr. David Porta for his never-ending support and
guidance. I would also like to thank my reader, Dr. Steven Wilt for his insightful feedback and
guidance throughout the thesis process. I would also like to thank Ms. Makayla Brady, Dr. David
Powell, and Dr. Mary Kroetz for their guidance in addition to providing space, resources, and
laboratory equipment. I would like to thank Dr. Dave Robinson for his valuable input and
suggestions. I would like to thank Dr. Jon Blandford and the Bellarmine University Honors
program for the opportunity to complete this study and their support in doing so. I would also
like to thank Mr. Rodney Guthrie, director of the Wright State University Boonshoft School of
Medicine Anatomical Gift Program, for giving permission for this study to occur. Finally, I
would like to thank the generous souls who bequeathed their bodies to the Anatomical Gift
Program for education and research.

Lynn 52
REFERENCES
Ad Zagga, A. T., Sm Ismail, H Ahmed Oon. (2013, July - August 2013). PCR Inhibitory Effects of
Aldehyde Fixing Agents on DNA Extracted from Embalmed Human Skeletal Fragments and
Teeth Specimens. IOSR Journal of Nursing and Health Science, 1(6), 33-37.
https://www.iosrjournals.org/iosr-jnhs/papers/vol1-issue6/G0163337.pdf?id=6561
Anandakrishnan, R., Carpenetti, T. L., Samuel, P., Wasko, B., Johnson, C., Smith, C., Kim, J.,
Michalak, P., Kang, L., Kinney, N., Santo, A., Anstrom, J., Garner, H. R., & Varghese, R. T.
(2020, Nov 16). DNA sequencing of anatomy lab cadavers to provide hands-on precision
medicine introduction to medical students. BMC Med Educ, 20(1), 437.
https://doi.org/10.1186/s12909-020-02366-0
Ayuso, T., Aznar, P., Soriano, L., Olaskoaga, A., Roldan, M., Otano, M., Ajuria, I., Soriano, G., Lacruz,
F., & Mendioroz, M. (2017). Vitamin D receptor gene is epigenetically altered and
transcriptionally up-regulated in multiple sclerosis. PLoS One, 12(3), e0174726.
https://doi.org/10.1371/journal.pone.0174726
Bagheri, M., Abdi Rad, I., Hosseini Jazani, N., & Nanbakhsh, F. (2013, Jul). Vitamin D Receptor TaqI
Gene Variant in Exon 9 and Polycystic Ovary Syndrome Risk. Int J Fertil Steril, 7(2), 116-121.
https://www.ncbi.nlm.nih.gov/pubmed/24520473
Bhat, I. A., Naykoo, N. A., Qasim, I., Ganie, F. A., Yousuf, Q., Bhat, B. A., Rasool, R., Aziz, S. A., &
Shah, Z. A. (2014, Dec). Association of interleukin 1 beta (IL-1beta) polymorphism with mRNA
expression and risk of non small cell lung cancer. Meta Gene, 2, 123-133.
https://doi.org/10.1016/j.mgene.2013.12.002
Chan, D., Song, Y., Sham, P., & Cheung, K. M. (2006, Aug). Genetics of disc degeneration. Eur Spine
J, 15 Suppl 3, S317-325. https://doi.org/10.1007/s00586-006-0171-3

Lynn 53
Doraisamy, R., Ramaswami, K., Shanmugam, J., Subramanian, R., & Sivashankaran, B. (2021, Jan).
Genetic risk factors for lumbar disc disease. Clin Anat, 34(1), 51-56.
https://doi.org/10.1002/ca.23641
Dydyk, A. M., Ngnitewe Massa, R., & Mesfin, F. B. (2021). Disc Herniation. In StatPearls.
https://www.ncbi.nlm.nih.gov/pubmed/28722852
Feng, Y., Egan, B., & Wang, J. (2016, Sep). Genetic Factors in Intervertebral Disc Degeneration. Genes
Dis, 3(3), 178-185. https://doi.org/10.1016/j.gendis.2016.04.005
Gielda, L., & Rigg, S. (2017, Dec 13). Extraction of amplifiable DNA from embalmed human cadaver
tissue. BMC Res Notes, 10(1), 737. https://doi.org/10.1186/s13104-017-3066-y
Holden, P., Canty, E. G., Mortier, G. R., Zabel, B., Spranger, J., Carr, A., Grant, M. E., Loughlin, J. A.,
& Briggs, M. D. (1999, Jul). Identification of novel pro-alpha2(IX) collagen gene mutations in
two families with distinctive oligo-epiphyseal forms of multiple epiphyseal dysplasia. Am J Hum
Genet, 65(1), 31-38. https://doi.org/10.1086/302440
Hwang, M. H., Cho, D. H., Baek, S. M., Lee, J. W., Park, J. H., Yoo, C. M., Shin, J. H., Nam, H. G.,
Son, H. G., Lim, H. J., Cho, H. S., Moon, H. J., Kim, J. H., Lee, J. K., & Choi, H. (2017, Nov).
Spine-on-a-chip: Human annulus fibrosus degeneration model for simulating the severity of
intervertebral disc degeneration. Biomicrofluidics, 11(6), 064107.
https://doi.org/10.1063/1.5005010
Korenberg, J. R., Chen, X. N., Doege, K., Grover, J., & Roughley, P. J. (1993, May). Assignment of the
human aggrecan gene (AGC1) to 15q26 using fluorescence in situ hybridization analysis.
Genomics, 16(2), 546-548. https://doi.org/10.1006/geno.1993.1228
Koshiba, M., Ogawa, K., Hamazaki, S., Sugiyama, T., Ogawa, O., & Kitajima, T. (1993, Feb). The
effect of formalin fixation on DNA and the extraction of high-molecular-weight DNA from fixed

Lynn 54
and embedded tissues. Pathol Res Pract, 189(1), 66-72. https://doi.org/10.1016/S03440338(11)80118-4
Leone, A., Cianfoni, A., Cerase, A., Magarelli, N., & Bonomo, L. (2011, Jun). Lumbar spondylolysis: a
review. Skeletal Radiol, 40(6), 683-700. https://doi.org/10.1007/s00256-010-0942-0
M. Konarzewska, Z. J., T. Malewski, I. Soltyszewski, W. Pepinski. (2019). Formalin fixed histological
specimens in DNA profiling of cadavers. Forensic Science International: Genetics Supplement
Series, 7(1), 325-326. https://doi.org/https://doi.org/10.1016/j.fsigss.2019.09.124 (October 01,
2019)
Middleton, K., & Fish, D. E. (2009, Jun). Lumbar spondylosis: clinical presentation and treatment
approaches. Curr Rev Musculoskelet Med, 2(2), 94-104. https://doi.org/10.1007/s12178-0099051-x
Ota, M., Fukushima, H., Kulski, J. K., & Inoko, H. (2007). Single nucleotide polymorphism detection by
polymerase chain reaction-restriction fragment length polymorphism. Nat Protoc, 2(11), 28572864. https://doi.org/10.1038/nprot.2007.407
Ravichandran, D., Pillai, J., & Krishnamurthy, K. (2022, Jan). Genetics of intervertebral disc disease: A
review. Clin Anat, 35(1), 116-120. https://doi.org/10.1002/ca.23803
Theodore, N. (2020, Jul 9). Degenerative Cervical Spondylosis. N Engl J Med, 383(2), 159-168.
https://doi.org/10.1056/NEJMra2003558
Theodore, N., Ahmed, A. K., Fulton, T., Mousses, S., Yoo, C., Goodwin, C. R., Danielson, J., Sciubba,
D. M., Giers, M. B., & Kalani, M. Y. S. (2019, Jun 1). Genetic Predisposition to Symptomatic
Lumbar Disk Herniation in Pediatric and Young Adult Patients. Spine (Phila Pa 1976), 44(11),
E640-E649. https://doi.org/10.1097/BRS.0000000000002949

Lynn 55
Viswanathan, V. K., & Subramanian, S. (2022). Pott Disease. In StatPearls.
https://www.ncbi.nlm.nih.gov/pubmed/30855915
Wang, Y., Jiang, L., Dai, G., Li, S., & Mu, X. (2018, Dec). Bioinformatics analysis reveals different
gene expression patterns in the annulus fibrosis and nucleus pulpous during intervertebral disc
degeneration. Exp Ther Med, 16(6), 5031-5040. https://doi.org/10.3892/etm.2018.6884
Waxenbaum, J. A., Reddy, V., & Futterman, B. (2021). Anatomy, Back, Intervertebral Discs. In
StatPearls. https://www.ncbi.nlm.nih.gov/pubmed/29262063
Wheeler, A., Czado, N., Gangitano, D., Turnbough, M., & Hughes-Stamm, S. (2017, Jan). Comparison
of DNA yield and STR success rates from different tissues in embalmed bodies. Int J Legal Med,
131(1), 61-66. https://doi.org/10.1007/s00414-016-1405-5
Xue, Y., & Fleet, J. C. (2009, Apr). Intestinal vitamin D receptor is required for normal calcium and
bone metabolism in mice. Gastroenterology, 136(4), 1317-1327, e1311-1312.
https://doi.org/10.1053/j.gastro.2008.12.051

Lynn 56
APPENDICES
Appendix A: DNeasy Blood & Tissue Kit Protocol
1. Cut tissue samples into small pieces that weigh less than 25 mg and place in 1.5 mL
microcentrifuge tubes.
2. Wash the samples twice with PBS by pipetting to remove any remaining formalin. Allow the
samples to sit in the PBS for 2 minutes during each wash.
3. Freeze the 1.5 mL microcentrifuge tubes in liquid nitrogen and grind the frozen tissue samples in
180 µL of Buffer ATL.
4. Once the tissue samples are ground up, add 20 µL of proteinase K and place the samples in a
shaking incubator. Allow the samples to incubate at 56 °C overnight to completely lyse the cells.
5. After the samples have incubated overnight, remove the tubes from the incubator and vortex
them for 15 seconds. Add 200 µL of Buffer AL and vortex the tubes.
6. Then, add 200 µL of 100% ethanol and vortex the tubes.
7. Place a DNeasy Mini spin column inside a 2 mL collection tube. Then, pipette the contents of the
microcentrifuge tube into the spin column. Centrifuge these spin columns for 1 minute at 8000
rpm. Dispose of the collection tube and the flow-through within it.
8. Place the spin column in a new 2 mL collection tube and pipette 500 µL of Buffer AW1 into the
spin column. Once again, centrifuge the spin column at 8000 rpm for 1 minute. Dispose of the
collection tube and flow-through.
9. Place the spin column in a new 2 mL collection tube and pipette 500 µL of Buffer AW2 into the
spin column. This time, centrifuge the spin columns at 14,000 rpm for 3 minutes. Dispose of the
collection tube and flow-through once again.
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10. Place the spin column in a 1.5 mL microcentrifuge tube and pipette 200 µL of Buffer AE into the
spin column. Allow the spin column to incubate at room temperature for 1 minute.
11. Centrifuge the spin column for 1 minute at 8000 rpm to elute the DNA. Add another 200 µL of
Buffer AE into the spin column and repeat this centrifugation into a second microcentrifuge tube
to maximize DNA yield.
12. Assess DNA for concentration and purity through the use of a Nanodrop spectrophotometer.
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Appendix B: 1% Agarose Gel Protocol
1. Weigh 1 g of agarose and place it into an Erlenmeyer flask.
2. Add 98 mL of deionized water and 2 mL of 50X TAE buffer from Bio-Rad to the Erlenmeyer
flask.
3. Microwave the Erlenmeyer flask until the agarose completely dissolves.
4. Add 5 µL of Apex Safe DNA Gel Stain from Genesee Scientific to the Erlenmeyer flask and
swirl the flask to mix the contents.
5. Decant the contents of the Erlenmeyer flask into a gel tray with well combs in place.
6. Allow the gel to solidify for 30 minutes at room temperature.
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Appendix C: Zymoclean Gel DNA Recovery Kit Protocol
1. Prior to beginning this protocol, add 24 mL of 100% ethanol to the 6 mL DNA Wash Buffer and
add 96 mL of 100% ethanol to the 24 mL DNA Wash Buffer. Depending on the number of preps
within the kit, these volumes may be different. Check the buffer bottles to determine the
appropriate volumes to add.
2. Excise the DNA band from the agarose gel using a sterile scalpel. Place the excised bands into
1.5 mL microcentrifuge tubes. Because the PCR reactions were run in duplicate, place bands
from both reactions of the same donor and gene into the same microcentrifuge tube.
3. Add 3 volumes of Buffer ADB for each volume of excised band to the microcentrifuge tube. For
this protocol, 1 mg is equivalent to 1 µL. If the excised band weighs 200 mg, then 600 µL of
Buffer ADB should be added to the microcentrifuge tube.
4. Incubate the microcentrifuge tube for 10 minutes in a 50 °C water bath. Vortex the tubes
occasionally during this incubation period.
5. Place a Zymo-Spin Column into a 2 mL collection tube. Decant the contents of the
microcentrifuge tube into the spin column.
6. Centrifuge the spin column at 8000 rpm for 1 minute. Dispose of the flow-through after
centrifugation.
7. Pipette 200 µL of DNA Wash Buffer into the spin column and centrifuge at 8000 rpm for 30
seconds. Dispose of the flow-through once again and repeat this washing step.
8. Place the spin column into a new 1.5 mL microcentrifuge tube, and pipette 30 µL of DNA
Elution Buffer into the spin column. Allow the spin column to incubate at room temperature for
1 minute.
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9. Centrifuge the spin column at 8000 rpm for 1 minute. Pipette the eluted DNA back into the spin
column and repeat this centrifugation to obtain ultra-pure DNA.
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Appendix D: QIAquick PCR and Gel Cleanup Kit Protocol
I.

QIAquick PCR Purification Kit Protocol
1. Prior to beginning this protocol, add 100% ethanol to Buffer PE. The Buffer PE bottle has the
volume of ethanol needed. Also, add a 1:250 volume of pH indicator to Buffer PB.
2. Add 5 volumes of Buffer PB to 1 volume of the PCR product and vortex. The solution should
remain a yellow color due to the pH indicator. If the solution turns orange or violet, add 10
µL of 3M sodium acetate with a pH of 5.
3. Place a QIAquick spin column in a 2 mL collection tube. Pipette the PCR product solution
into the spin column and centrifuge at 13,000 rpm for 1 minute. Dispose of the flow-through
and place the spin column back in the collection tube.
4. Pipette 750 µL of Buffer PE to the spin column and centrifuge at 13,000 rpm for 1 minute.
Without adding more buffer, repeat this centrifugation for 1 minute to remove any residual
buffer in the spin column.
5. Place the spin column in a new 1.5 mL microcentrifuge tube. Pipette 30 µL of sterile
nuclease-free water into the spin column and allow it to incubate at room temperature for 5
minutes.
6. Centrifuge the spin column at 13,000 rpm for 1 minute. Without adding any more sterile
nuclease-free water, centrifuge the spin column a second time.
7. This purified DNA can now be used for sequencing.

II.

QIAquick Gel Extraction Kit
1. Prior to beginning this protocol, add 100% ethanol to Buffer PE. The Buffer PE bottle has the
required volume of ethanol needed.
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2. Excise the DNA band from the agarose gel using a sterile scalpel. Place the excised bands
into 1.5 mL microcentrifuge tubes. Because the PCR reactions were run in duplicate, place
bands from both reactions of the same donor and gene into the same microcentrifuge tube.
3. Add 3 volumes of Buffer QG for each volume of excised band to the microcentrifuge tube.
For this protocol, 1 mg is equivalent to 1 µL. If the excised band weighs 200 mg, then 600
µL of Buffer QG should be added to the microcentrifuge tube.
4. Incubate the microcentrifuge tube for 10 minutes in a 50 °C water bath. Vortex the tubes
occasionally during this incubation period. The color of the solution should be yellow. If the
solution turns orange or violet, add 10 µL of 3M sodium acetate with a pH of 5.
5. Add 1 gel volume of isopropanol to the microcentrifuge tube.
6. Place a QIAquick spin column in a 2 mL collection tube and pipette the microcentrifuge tube
contents into the spin column. Centrifuge the spin column at 13,000 rpm for 1 minute.
Dispose of the flow-through and place the spin column back in the 2 mL collection tube.
8. Pipette 500 µL of Buffer QG into the spin column and centrifuge at 13,000 rpm for 1 minute.
Once again, dispose of the flow-through and place the spin column back into the 2 mL
collection tube.
9. Pipette 750 µL of Buffer PE to the spin column and allow it to incubate for 5 minutes at
room temperature.
10. Centrifuge the spin column at 13,000 rpm for 1 minute. Dispose of the flow-through and
place the spin column back into the 2 mL collection tube. Without adding more buffer, repeat
this centrifugation. After the second centrifugation, place the spin column in a new 1.5 mL
microcentrifuge tube.

Lynn 63
11. Pipette 30 µL of sterile nuclease-free water into the spin column and allow it to incubate at
room temperature for 5 minutes.
12. Centrifuge the spin column at 13,000 rpm for 1 minute. Without adding any more sterile
nuclease-free water, centrifuge the spin column a second time.
13. This purified DNA can now be used for sequencing.

